Published in Proc Natl Acad Sci U S A on March 28, 1995
Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res (2007) 1.54
Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol (2000) 1.29
3D single molecule tracking with multifocal plane microscopy reveals rapid intercellular transferrin transport at epithelial cell barriers. Biophys J (2012) 1.22
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release (2009) 1.10
Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol (2000) 1.10
Emerging insights into barriers to effective brain tumor therapeutics. Front Oncol (2014) 1.08
Developing therapeutic antibodies for neurodegenerative disease. Neurotherapeutics (2013) 1.05
Immunotherapy for Alzheimer's disease: past, present and future. Front Aging Neurosci (2014) 0.99
Emerging mass spectrometry-based approaches to probe protein-receptor interactions: focus on overcoming physiological barriers. Adv Drug Deliv Rev (2013) 0.84
In vivo role of B lymphocytes in somatic transgene immunization. Proc Natl Acad Sci U S A (1997) 0.82
Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate. Mol Pharm (2013) 0.80
Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery. PLoS One (2013) 0.79
Iron uptake and transport across physiological barriers. Biometals (2016) 0.78
Pharmacokinetics of recombinant bifunctional fusion proteins. Expert Opin Drug Metab Toxicol (2012) 0.77
Applications of ApoB LDLR-Binding Domain Approach for the Development of CNS-Penetrating Peptides for Alzheimer's Disease. Methods Mol Biol (2015) 0.76
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. Curr Pharm Des (2016) 0.76
Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.75
Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation. Neurosurgery (2016) 0.75
Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J Biol Chem (1983) 4.55
Transferrin receptor on endothelium of brain capillaries. Nature (1984) 3.37
The binding site for C1q on IgG. Nature (1988) 3.03
The physiology of transferrin and transferrin receptors. Physiol Rev (1987) 2.60
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45
Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J (1988) 2.40
Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol (1990) 2.23
Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions. J Immunol (1980) 2.06
Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J Immunol (1980) 2.03
The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med (1991) 1.88
Electrical resistance of brain microvascular endothelium. Brain Res (1982) 1.87
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A (1991) 1.85
Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9. J Biol Chem (1982) 1.84
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature (1988) 1.67
Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res (1987) 1.51
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42
The blood-brain barrier. Sci Am (1986) 1.38
Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35
Production and properties of chimeric antibody molecules. Methods Enzymol (1989) 1.35
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther (1991) 1.32
Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc (1984) 1.25
Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science (1993) 1.25
Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc Natl Acad Sci U S A (1991) 1.23
Human blood-brain barrier insulin-like growth factor receptor. Metabolism (1988) 1.05
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci U S A (1993) 1.01
Similarities between the transferrin receptor proteins on human reticulocytes and human placentae. J Biol Chem (1981) 0.98
Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain. J Neurosurg (1984) 0.95
Production and characterization of genetically engineered antibody molecules. Clin Chem (1988) 0.94
Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells. J Cell Physiol (1991) 0.92
Recombinant polymeric IgG: an approach to engineering more potent antibodies. Biotechnology (N Y) (1994) 0.85
Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab (1991) 0.84
Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting. Proc Natl Acad Sci U S A (1990) 0.81
Functional properties of antibody insulin-like growth factor fusion proteins. J Biol Chem (1994) 0.80
Concentration of transferrin receptor in human placental coated vesicles. J Cell Biol (1989) 0.79
Nerve growth factor as a potential treatment in Alzheimer's disease. Biomed Pharmacother (1989) 0.78
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (1990) 5.57
Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A (1983) 5.18
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 3.32
Genome duplication in soybean (Glycine subgenus soja). Genetics (1996) 3.14
Nucleotide sequence of the ilvB promoter-regulatory region: a biosynthetic operon controlled by attenuation and cyclic AMP. Proc Natl Acad Sci U S A (1982) 2.50
Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev (1983) 2.46
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem (1990) 2.45
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol (1989) 2.42
Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J (1988) 2.40
Presentation and outcome of incarcerated external hernias in adults. Am J Surg (2001) 2.15
Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology (1990) 2.13
Design and production of novel tetravalent bispecific antibodies. Nat Biotechnol (1997) 2.13
Natural history of unstable angina. Lancet (1972) 2.03
New technique for inguinal hernia repair. Hernia (2004) 1.99
Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res (1995) 1.97
Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A (1999) 1.93
Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91
A quantitative difference in the immune response between male and female mice. Proc Soc Exp Biol Med (1968) 1.90
The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med (1991) 1.88
Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry (1995) 1.87
Polypeptide products of nonsense mutations. I. Termination fragments from nonsense mutations in the Z gene of the lac operon of Escherichia coli. J Mol Biol (1970) 1.84
Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice. Endocrinology (2012) 1.81
The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function. Mol Cell Biol (1989) 1.81
Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods (1992) 1.74
Transport of metabolic substrates through the blood-brain barrier. J Neurochem (1977) 1.73
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
Emergency hernia repairs in elderly patients. Am J Surg (2001) 1.73
Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther (2000) 1.63
Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol (2012) 1.63
Thyroid function in nonthyroidal illnesses. Ann Intern Med (1983) 1.62
Alcohol consumption among HIV-infected patients. J Gen Intern Med (1995) 1.62
Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev (2001) 1.62
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol (1990) 1.57
The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord (2005) 1.54
Mediated efflux of IgG molecules from brain to blood across the blood-brain barrier. J Neuroimmunol (2001) 1.52
Human blood-brain barrier transferrin receptor. Metabolism (1987) 1.50
Murine heavy chain disease. Eur J Immunol (1978) 1.50
The ilvB locus of Escherichia coli K-12 is an operon encoding both subunits of acetohydroxyacid synthase I. Nucleic Acids Res (1985) 1.49
Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab (1997) 1.48
Human blood-brain barrier insulin receptor. J Neurochem (1985) 1.47
Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? Ann Neurol (1994) 1.46
Reduced expression of the isoleucine and valine enzymes in integration host factor mutants of Escherichia coli. J Mol Biol (1984) 1.45
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest (1997) 1.43
Absorptive-mediated endocytosis of cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J Biol Chem (1987) 1.42
Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42
Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A (2000) 1.42
Nucleolar localization of human methionyl-tRNA synthetase and its role in ribosomal RNA synthesis. J Cell Biol (2000) 1.42
Cloning and expression of the ilvB gene of Escherichia coli K-12. Mol Gen Genet (1982) 1.42
Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res (1987) 1.42
Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res (2001) 1.42
Measurement of radiation dose distributions by nuclear magnetic resonance (NMR) imaging. Phys Med Biol (1984) 1.41
A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Anal Biochem (1991) 1.40
Bioavailable testosterone in salivary glands. Clin Chem (1991) 1.39
Admission criteria for handicapped students. Nurs Outlook (1989) 1.39
Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc Natl Acad Sci U S A (1989) 1.39
Estimation of antibodies specific for dextran. J Immunol (1978) 1.38
Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest (1997) 1.37
Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother (2001) 1.36
Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev (1986) 1.35
Production and properties of chimeric antibody molecules. Methods Enzymol (1989) 1.35
Apoptosis signal-regulating kinase 1 controls the proapoptotic function of death-associated protein (Daxx) in the cytoplasm. J Biol Chem (2001) 1.34
Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas. J Immunol (1986) 1.34
Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol (2005) 1.33
Kinetics of blood-brain barrier transport of pyruvate, lactate and glucose in suckling, weanling and adult rats. J Neurochem (1979) 1.33
Kinetics of blood-brain transport of hexoses. Biochim Biophys Acta (1975) 1.32
Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol (1997) 1.32
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res (2000) 1.31
Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure). Proc Natl Acad Sci U S A (1972) 1.31
Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28
TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J Immunol (1999) 1.28
Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg (2004) 1.28
Inter- and intra-observer variation of the Schatzker and AO/OTA classifications of tibial plateau fractures and a proposal of a new classification system. Ann R Coll Surg Engl (2007) 1.28
Which way kaikai blo umi? Food and nutrition in the Torres Strait. Aust J Public Health (1995) 1.27
Different VL and VH germ-line genes are used to produce similar combining sites with specificity for alpha(1----6)dextrans. J Immunol (1987) 1.27
Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin Immunol (2001) 1.26
Dietary experience and sweet taste preference in human infants. Appetite (1982) 1.26
Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med (1987) 1.26
Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. Proc Natl Acad Sci U S A (1990) 1.26
Identification of a ribosomal protein essential for peptidyl transferase activity. Proc Natl Acad Sci U S A (1975) 1.24
Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A (1991) 1.24
Myeloma mutant with a novel 3' flanking region: loss of normal sequence and insertion of repetitive elements leads to decreased transcription but normal processing of the alpha heavy-chain gene products. Mol Cell Biol (1986) 1.21
Transfectomas provide novel chimeric antibodies. Science (1985) 1.20
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res (1994) 1.20
hnRNP A2 and hnRNP L bind the 3'UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun (1999) 1.19
Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol (1999) 1.19
Policy for early discharge after acute myocardial infarction. Br Med J (1980) 1.19
Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc Natl Acad Sci U S A (1999) 1.19
Bone-marrow suppression associated with cimetidine. Ann Intern Med (1979) 1.17
Sequentially derived mutants of the constant region of the heavy chain of murine immunoglobulins. J Immunol (1979) 1.16
Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem (1977) 1.16
Galectin-1 induces partial TCR zeta-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol (2000) 1.16
Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells. Mol Cell Biol (1986) 1.16
Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1. J Exp Med (1994) 1.16
Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. J Immunol (1998) 1.15